Sector portfolio · VC firm · United States
Johnson & Johnson Development Corporation (JJDC)'s Biotech portfolio
Johnson & Johnson Development Corporation (JJDC) has backed 21 Biotech startups in rounds we track, $3.0B between them, shown by the stage each has reached. The best-funded is 23andme.
Johnson & Johnson Development Corporation (JJDC)'s whole portfolioJohnson & Johnson Development Corporation (JJDC)'s profile
Funding by segment
- Series C and later$2.1B12
- Stage not reported$638M5
- Series A$66M2
- Series B$209M2
Where they are based
- United States15$2.6B
- United Kingdom3$280M
- Australia1$89M
- Belgium1$39M
United States
United Kingdom
Australia
BelgiumFounded
3 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M6
- $50M to $250M13
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
18 of 21 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States15
- United Kingdom3
- Australia1
- Belgium1
Startups by country, 4 countries in all.
Segment by segment
Series C and later
12 startups · $2.1B raised
23andMeUnited States$729M
CVRxCVRx is a medical device company developing implantable technology for the treatment of high blood pressure.United States$369M
ViaCyteViaCyte is a cellular therapy and regenerative medicine company based in San Diego, California.United States$188M
ReVision OpticsReVision Optics offers PRESBYLENS, a refractive surgery solution to correct vision loss by the natural aging process.United States$172M- OBOptiScan BiomedicalUnited States$121M
- AGAtlas GeneticsUnited Kingdom$111M
PulmocidePulmocide is a private biopharmaceutical company based in London, United Kingdom, founded in 2007.United Kingdom$110M- PPowerVisionPowerVision is a device company developing implantable intraocular lenses.United States$108M
Stage not reported
5 startups · $638M raised
CelladonCelladon is a biotechnology company developing molecular therapies for the treatment of heart failure.United States$172M- NNeotractNeoTract develops surgical devices for urological and gynecological disorders.United States$158M
IntrapaceIntraPace Casino Next generation casino entertainment: Experience the combination of innovation, awareness and precision with play.United States$144M
NeuroPaceNeuroPace develops and markets implantable devices for the treatment of neurological disorders.United States$141M- CSCyrano SciencesCyrano Sciences, is focused on providing chemical and biological sensors and software solutions.United States$23M
Series A
2 startups · $66M raised
OptherionOptherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment United States$42M
Navitor PharmaceuticalsNavitor Pharmaceuticals is an early-stage biopharmaceutical company co-founded by David Sabatini.United States$24M
Series B
2 startups · $209M raised
Cardiac DimensionsCardiac Dimensions is a medical device company based in Kirkland, Washington, founded in 2001.United States$150M- IInivataUnited Kingdom$59M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Johnson & Johnson Development Corporation (JJDC) as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Johnson & Johnson Development Corporation (JJDC)?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.